United Kingdom
April 2, 2013

Plant Health Care (AIM / CISX: PHC.L), a leading provider of novel patent protected biological products to the global agriculture markets confirms that, further to the announcement of 26 March 2013, Mr Paul Schmidt has today been appointed the Company’s Chief Executive Officer and that Mr John Brady, former CEO, has stepped down from this role but remains as a non-executive director on the Plant Health Care Board. In addition, Mr Sam Wauchope has stepped down from the Board today, following nine years as a non-executive director and a stint as Interim Chairman in 2012.

The Company is pleased to welcome Paul Schmidt. Mr Schmidt, age 54, has extensive operational experience in the agriculture industry, having served in senior roles in the USA, Germany and Canada during 25 years with Bayer CropScience and its predecessor companies. As President of Merck/EMD Crop Bioscience, a leading developer of natural plant health products, Paul led a turnaround which resulted in substantially increased sales and profit. In February 2011, he oversaw the sale of the business to Novozymes for $275 million. Paul graduated from the University of Saskatchewan with a BSA in Agronomy in 1980.

Dr. Christopher Richards, Chairman commented: “I would like to reiterate my thanks to both John and Sam for all that they have done for Plant Health Care. Securing the services of Paul as the Company’s new CEO is a real coup. Paul’s extensive experience in the industry leaves us very well positioned to progress to the next stage in the Company’s development. I am convinced that Paul has the right qualities to lead Plant Health Care to this next level.”

Website: http://www.planthealthcare.co.uk

Published: April 2, 2013